Editorial: How does the risk of hepatocellular carcinoma change over time in patients with a hepatitis C cure?
Aliment Pharmacol Ther
.
2024 Feb;59(3):417-418.
doi: 10.1111/apt.17818.
Author
Hamish Innes
1
2
3
Affiliations
1
School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.
2
Public Health Scotland, Glasgow, UK.
3
Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK.
PMID:
38197713
DOI:
10.1111/apt.17818
No abstract available
Publication types
Editorial
MeSH terms
Carcinoma, Hepatocellular*
Hepacivirus
Hepatitis C* / complications
Hepatitis C* / drug therapy
Humans
Liver Neoplasms*
Grants and funding
29725/CRUK_/Cancer Research UK/United Kingdom